| Date Filed | Type | Description |
| 02/15/2019 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 01/15/2019 |
SC 13D/A
| AISLING CAPITAL III LP reports a 6.7% stake in Loxo Oncology, Inc. |
| 07/12/2018 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 07/12/2018 |
4
| AISLING CAPITAL III LP (10% Owner) has filed a Form 4 on Loxo Oncology, Inc.|
Txns:
| Sold 1,400,000 shares
@ $179.43, valued at
$251.2M
|
|
| 06/05/2018 |
SC 13D/A
| AISLING CAPITAL III LP reports a 3.1% stake in TransEnterix, Inc. |
| 02/07/2018 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/07/2018 |
SC 13G/A
| AISLING CAPITAL III LP reports a 0% stake in T2 Biosystems, Inc. |
| 02/07/2018 |
SC 13G/A
| AISLING CAPITAL III LP reports a 4.4% stake in Aimmune Therapeutics, Inc. |
| 02/01/2018 |
SC 13D/A
| AISLING CAPITAL III LP reports a 1.9% stake in Pernix Therapeutics Holdings, Inc. |
| 02/01/2018 |
SC 13D/A
| AISLING CAPITAL III LP reports a 3.8% stake in Agile Therapeutics, Inc. |
| 12/20/2017 |
4
| AISLING CAPITAL III LP (10% Owner) has filed a Form 4 on Loxo Oncology, Inc.|
Txns:
| Sold 250,000 shares
@ $80.5, valued at
$20.1M
|
|
| 11/28/2017 |
SC 13D/A
| AISLING CAPITAL III LP reports a 12.3% stake in Loxo Oncology, Inc. |
| 11/27/2017 |
4
| AISLING CAPITAL III LP (10% Owner) has filed a Form 4 on Loxo Oncology, Inc.|
Txns:
| Sold 500,000 shares
@ $75, valued at
$37.5M
|
|
| 05/09/2017 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 02/03/2017 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals [Amend] |
| 02/03/2017 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals [Amend] |
| 02/03/2017 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals [Amend] |
| 01/12/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 01/12/2017 |
SC 13D/A
| Loxo Oncology, Inc. reports a 16.4% stake in Loxo Oncology, Inc. |
| 10/27/2016 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership [Amend] |
| 10/03/2016 |
SC 13D/A
| AISLING CAPITAL III LP reports a 7.9% stake in Agile Therapeutics, Inc. |
| 07/06/2016 |
4
| AISLING CAPITAL III LP (10% Owner) has filed a Form 4 on Syros Pharmaceuticals, Inc.|
Txns:
| Converted 508,565 shares
@ $0
Bought 400,000 shares
@ $12.5, valued at
$5M
Converted 1,907,122 preferred shares
@ $0 |
|
| 06/29/2016 |
3
| Form 3 - Initial statement of beneficial ownership of securities |
| 06/03/2016 |
4
| AISLING CAPITAL III LP (10% Owner) has filed a Form 4 on AGILE THERAPEUTICS INC|
Txns:
| Disposed of 400,000 shares
@ $0 |
|
| 05/19/2016 |
4
| AISLING CAPITAL III LP (10% Owner) has filed a Form 4 on Loxo Oncology, Inc.|
Txns:
| Bought 232,558 shares
@ $21.5, valued at
$5M
|
|
| 02/05/2016 |
SC 13G/A
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend] |
| 02/05/2016 |
5
| Form 5 - Annual statement of changes in beneficial ownership of securities |
| 02/05/2016 |
SC 13D/A
| Form SC 13D - General statement of acquisition of beneficial ownership [amend] |
| 12/15/2015 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 12/09/2015 |
4
| AISLING CAPITAL III LP (10% Owner) has filed a Form 4 on T2 Biosystems, Inc.|
Txns:
| Bought 307,692 shares
@ $9.75, valued at
$3M
|
|
| 11/19/2015 |
4
| AISLING CAPITAL III LP (10% Owner) has filed a Form 4 on Loxo Oncology, Inc.|
Txns:
| Bought 265,000 shares
@ $26.5, valued at
$7M
|
|
| 11/16/2015 |
4
| AISLING CAPITAL III LP (10% Owner) has filed a Form 4 on Loxo Oncology, Inc.|
Txns:
| Bought 76,714 shares
@ $27.6523, valued at
$2.1M
Bought 1,955 shares
@ $27.4702, valued at
$53.7k
|
|
| 01/29/2015 |
4
| AISLING CAPITAL III LP (10% Owner) has filed a Form 4 on Versartis, Inc.|
Txns:
| Bought 145,000 shares
@ $17.25, valued at
$2.5M
|
|
| 01/27/2015 |
4
| AISLING CAPITAL III LP (10% Owner) has filed a Form 4 on AGILE THERAPEUTICS INC|
Txns:
| Bought 811,966 shares
@ $5.85, valued at
$4.8M
|
|
|